| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/23/2008 | CN100403923C Process for reducing the acrylamide content of heat-treated foods |
| 07/22/2008 | US7402735 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
| 07/22/2008 | US7402734 Using counter rotating mechanical device for separation of embryos from seeds; plant tissue culture and embryo transplantation; preparing crops with improved yield, insect and disease resistance, herbicide tolerance, and increased nutritional value |
| 07/22/2008 | US7402733 Transgenic expression cassettes for expressing nucleic acids in non-reproductive floral tissues of plants |
| 07/22/2008 | US7402732 Paraquat resistance gene and a vascular tissue—and trichome-specific promoter |
| 07/22/2008 | US7402731 Identification of seeds or plants using phenotypic markers |
| 07/22/2008 | US7402730 Knockout animals manifesting hyperlipidemia |
| 07/22/2008 | US7402729 Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 07/22/2008 | US7402728 Transgenic mice expressing human CD20 and/or CD16 |
| 07/22/2008 | US7402727 Model produced by injecting an immunodeficient mouse with a suspension of single cells of human small cell lung carcinoma SBC-5 cells to effect metastasis in the mouse's own bone; used for screening anticancer drugs |
| 07/22/2008 | US7402671 UV excitable fluorescent energy transfer dyes |
| 07/22/2008 | US7402667 Promoter, promoter control elements, and combinations, and uses thereof |
| 07/22/2008 | US7402664 Nucleic acids and expression vectors comprising carotenoid binding peptides |
| 07/22/2008 | US7402662 Antibody molecules specific to human tumor necrosis factor alpha |
| 07/22/2008 | US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein |
| 07/22/2008 | US7402659 Recombinant cytokine for diagnosis, prevention and treatment of tissue-degenerating disorders |
| 07/22/2008 | US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family |
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402574 Antisense composition and method for treating cancer |
| 07/22/2008 | US7402573 Use of nanoparticles for the DNA administration to a target organ |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402571 Methods and pharmaceutical compositions for healing wounds |
| 07/22/2008 | US7402570 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 07/22/2008 | US7402563 EPF derived peptides and therapeutic compositions |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402436 Lentiviral vectors for site-specific gene insertion |
| 07/22/2008 | US7402435 Using cold gas plasma to insert DNA sequences into cells; transformation and genetic engineering |
| 07/22/2008 | US7402434 Splice choice antagonists as therapeutic agents |
| 07/22/2008 | US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders |
| 07/22/2008 | US7402429 Stably transfected plasmids that express polymerase, viral proteins from measles or mumps; Paramyxoviridae; use in vaccines or gene therapy |
| 07/22/2008 | US7402428 DNA construct comprising a promoter linked to gene involved in monolignol biosynthetic pathway |
| 07/22/2008 | US7402427 Genomic RNA of paramyxovirus encoding M and F proteins; decreased production of viral particles; suppresses cancer growth |
| 07/22/2008 | US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/22/2008 | US7402420 Comprises nucleotide sequences coding alternan for preparing cosmetics and food stuffs |
| 07/22/2008 | US7402419 Oxidoreductase comprising enhanced thermostability for use as nicotinamide adenine dinucleotide phosphate regenerative tool |
| 07/22/2008 | US7402418 Genes participating in the synthesis of fatty acid having trans-11-,cis-13-conjugated double bond and utilization thereof |
| 07/22/2008 | US7402417 P450 oxygenases and methods of use |
| 07/22/2008 | US7402415 Method for the production of glycerol by recombinant organisms |
| 07/22/2008 | US7402413 Method of expressing long-chain prenyl diphosphate synthase |
| 07/22/2008 | US7402410 Humanized immunoglobulin reactive with α4β7 integrin |
| 07/22/2008 | US7402400 Membrane protein for use in quality control in food processing |
| 07/22/2008 | US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/22/2008 | US7402394 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 07/22/2008 | US7402393 Methods of screening for antagonists of APM1/GZIP |
| 07/22/2008 | US7402391 Method for detecting target plant genus |
| 07/22/2008 | US7402388 Using immunophilin (FKBP54) expression as diagnostic/prognostic indicator of cell proliferative disorders; antitumor agents |
| 07/22/2008 | US7402387 Using mutation in intron-exon boundary of dihydropyrimidine dehydrogenase as indicator for modifying cancer treatment protocol |
| 07/22/2008 | US7402384 Immobilization; controlling length; coupling to label; biosynthesis |
| 07/22/2008 | US7402383 Using site directed mutagenesis and polymerase chain reaction replication to produce polypeptides of preferential characteristics; directed protein evolution |
| 07/22/2008 | US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines |
| 07/22/2008 | US7402314 Antigen peptides; medical diagnosis |
| 07/22/2008 | US7402310 Deoxyribonuclease, gene encoding same and use thereof |
| 07/22/2008 | US7402309 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions |
| 07/22/2008 | US7402308 Method of delivering genes to the central nervous system of a mammal |
| 07/22/2008 | US7402306 Cancer immunotherapy with semi-allogeneic cells |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 07/22/2008 | US7402303 Chemokine mutants in the treatment of multiple sclerosis |
| 07/22/2008 | CA2539069C Process for producing carotenoid compound |
| 07/22/2008 | CA2384911C Method for the screening of .alpha.2. delta.-1 subunit binding ligands |
| 07/22/2008 | CA2366778C Methods for detecting nucleic acids indicative of cancer |
| 07/22/2008 | CA2326828C Stent with smooth ends |
| 07/22/2008 | CA2282706C Adenovirus vectors specific for cells expressing .alpha.-fetoprotein and methods of use thereof |
| 07/22/2008 | CA2274474C Synthetic hpv16 virus-like particles |
| 07/22/2008 | CA2244115C Method of plasmid dna production and purification |
| 07/22/2008 | CA2240334C Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus and mutant enzymes thereof with exonuclease activity removed |
| 07/22/2008 | CA2238296C Ultrathermostable protease genes |
| 07/22/2008 | CA2220880C Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
| 07/22/2008 | CA2220588C Attenuated live neospora vaccine |
| 07/22/2008 | CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 07/22/2008 | CA2163805C Novel activating factor of leukocytes |
| 07/22/2008 | CA2141427C Expression of recombinant fusion proteins in attenuated bacteria |
| 07/22/2008 | CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto |
| 07/22/2008 | CA1341578C Plants with modified stamen cells |
| 07/22/2008 | CA1341577C Expression of biologically active factor xiii |
| 07/21/2008 | CA2675207A1 Production of arachidonic acid in oilseed plants |
| 07/17/2008 | WO2008086529A2 Compositions and methods for targeted inactivation of hiv cell surface receptors |
| 07/17/2008 | WO2008086466A1 Enzyme production in culture medium comprising raw glycerol |
| 07/17/2008 | WO2008086386A2 Adenoviral vector-based malaria vaccines |
| 07/17/2008 | WO2008086035A2 Split mutant hydrolase fusion reporter and uses thereof |
| 07/17/2008 | WO2008086003A1 Methods for selecting improved strains |
| 07/17/2008 | WO2008085962A2 Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants |
| 07/17/2008 | WO2008085956A2 High expression cell line that eliminates gene amplification |
| 07/17/2008 | WO2008085951A2 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |
| 07/17/2008 | WO2008085912A1 Compositions of and methods of using sulfatases from flavobacterium heparinum |
| 07/17/2008 | WO2008085891A1 Oocyte spindle-associated factors improve somatic cell cloning |
| 07/17/2008 | WO2008085605A2 Backbone-free low transgene copy transgenic plants |
| 07/17/2008 | WO2008085563A1 Recombinant viral proteins and particles |
| 07/17/2008 | WO2008085543A2 Multimeric elp fusion constructs |
| 07/17/2008 | WO2008084869A1 Single-molecule-type bioluminescence imaging probe |
| 07/17/2008 | WO2008084849A1 Cadaverine salt, aqueous cadaverine salt solution, polyamide resin, molded article and process for producing cadaverine salt and aqueous cadaverine salt solution |
| 07/17/2008 | WO2008084672A1 Method for confirming performance of optical detector and reference reagent used for same |
| 07/17/2008 | WO2008084652A1 Vascular endothelial cell-binding peptide |
| 07/17/2008 | WO2008084571A1 Nucleic-acid-reactive gel, method for production of the gel, and use of the gel |
| 07/17/2008 | WO2008084566A1 Model mouse, method of constructing the same and use thereof |
| 07/17/2008 | WO2008084329A2 Novel rucola plants with cytoplasmic male sterility (cms) |
| 07/17/2008 | WO2008084319A2 Novel nucleic acid |
| 07/17/2008 | WO2008084115A2 Lactococcus promoters and uses thereof |
| 07/17/2008 | WO2008084107A1 Fad2 mutants and high oleic acid plants |